eyeforpharma.com
- Who is Mal Barnard?
- Forecasting opportunities in the Middle Eastern mark...
- Best practice in modeling and forecasting
- Designing adherence programs: Local is better than g...
- Compliance and the corporate brand
- The future of pharma: When it comes to strategy, one...
- Market access: risk sharing and alternative pricing ...
- Market access and patient access schemes
- Market access: how to get REMS right
- The pharma marketer as change agent
- More items from this source »
Food and Drug Administration - Press Releases
- FDA seeks court order against Michigan dairy
- FDA launches new organizational performance manageme...
- FDA Warns Consumers to Avoid TimeOut Capsules
- FDA releases guidance on federal menu labeling requi...
- FDA Warns of Possible Dangers from Portable Foot-Tan...
- Study: Presence of murine leukemia virus found in CF...
- Urgent Nationwide Frozen Mamey Fruit Products Recall
- Urgent Nationwide Egg Recall
- U.S. Marshals seize food from rodent-infested Ga. wa...
- FDA Proposes Withdrawal of Low Blood Pressure Drug
- More items from this source »
Pharma Industry News From Medical News Today
- Orexigen Partners With Takeda To Commercialize Obesi...
- Therapeutic Workshops To Highlight Opportunities In ...
- Eisai Announces The Start Of The First Clinical Stud...
- BRINAVESS™ (vernakalant) For Infusion Approved In Th...
- Novartis Drug Tasigna® Approved In Switzerland After...
- Roche Provides Update On FDA Application For T-DM1
- QRxPharma Announces Interim Analysis Of Final Pivota...
- Agensys, An Affiliate Of Astellas, Announces Initiat...
- Proprietary Zinc/Phytase Formulation Improved Botuli...
- ReVision's Fenretinide (RT-101) Reduced Incidence Of...
- More items from this source »
PharmaNews.eu
- Starting signal sounded: analytica 2012 to offer Ear...
- Data from Mipomersen Phase 3 Trial in heFH Patients ...
- Global market launch of Daxas® (Roflumilast) kicks o...
- A new era for patients with atrial fibrillation - Da...
- European Medicines Agency starts review of Pandemrix
- Genetic substudy shows fewer major cardiovascular ev...
- Shire Announces European Approval of VPRIV® (velaglu...
- Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet N...
- GSK European Commission amends licence for Cervarix®...
- Change in environment sparks stem cell cross-over
- More items from this source »
PharmiWeb.com
- Quick Look: Dementia
- Rexahn Pharmaceuticals Announces Publication of New ...
- PerkinElmer OneSource Extends Service Contract with ...
- Systech and Marchesini Showcase Integrated Platform ...
- BRINAVESS™ (vernakalant) for Infusion Approved in th...
- HTG Announces Appointments of John Wineman as Vice P...
- Allergan Resolves United States Government Investiga...
- Cellerant Therapeutics Awarded $153 Million Contract...
- Stockholm-Uppsala Professor receives prestigious car...
- Clinigen Announces Group Management Changes
- More items from this source »
What's New: Drugs on FDA.gov
- Safe Drug Use After a Natural Disaster
- Information Regarding Insulin Storage and Switching ...
- FDA Drug Safety Communication: Increased risk of dea...
- Potential Signals of Serious Risks/New Safety Inform...
- September 20, 2010: Cardiovascular and Renal Drugs A...
- FDA Drug Safety Communication: New boxed warning for...
- FDA Drug Safety Communication: Ongoing Safety Review...
- Additions/Deletions for Prescription and OTC Drug Pr...
- Orange Book Zip File
- FDA Drug Safety Communication: Aseptic meningitis as...
- More items from this source »